Urinary eosinophil protein X in relation to disease activity in childhood asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue 5, 1997, Pages 584-588

  Lugosi, E ^a   Halmerbauer, G ^a   Frischer, T ^a   Koller, D Y ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Asthma; Children; Eosinophil protein X (EPX); Pulmonary function; Urine

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CREATININE; CROMOGLYCATE DISODIUM; FLUTICASONE; PROTEIN; STEROID;

ARTICLE; ASTHMA; ATOPY; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; EOSINOPHIL; FEMALE; HUMAN; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; LEUKOCYTE ACTIVATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN URINE LEVEL;

EID: 0030806765     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb02605.x     Document Type: Article

References (18)

1. Dahl R, Venge P, Fredens K. Eosinophils. In: Barnes PJ, Rodger JW, Thomson NC, editors. Asthma - basic mechanisms and clinical management. 2nd ed. London: Academic Press. 1992:111-24.
2. Götz M, Koller DY, Wojnarowski C, Herouy Y. Immuno-allergologic aspects of childhood asthma. Agents Actions Suppl 1993;40:153-65.
3. Ahlstedt S, Enander I, Peterson C, Rak S, Venge P. Clinical assessment of the inflammatory component of asthma with emphasis on the eosinophils. Pharm Med 1992;6:99-111.
4. Gleich GJ. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol 1990;85:422-36.
5. Koller DY, Urbanek R, Götz M. Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis. Am J Respir Crit Care Med 1995;152:629-33.
6. Hällgren R, Venge P. The eosinophil in inflammation. In: Matsson P, Ahlstedt S, Venge P, Thorell J, editors. Clinical impact of monitoring of allergic inflammation. London: Academic Press, 1991:119-40.
7. Carlson M, Håkansson L, Peterson C, Stålenheim G, Venge P. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991;87:27-33.
8. Slifman NR, Peterson CGB, Venge R Dunette SL, Gleich GJ. Eosinophil derived neurotoxin and eosinophil protein X: comparison of physicochemical, enzymatic and immunologic properties. J Immunol 1989;143:2317-22.
9. Fredens K, Dahl R, Venge P. The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. J Allergy Clin Immunol 1982;70:361-6.
10. Virchow JC Jr, Holscher U, Virchow C Sr. Sputum ECP levels correlate with parameters of airflow obstruction. Am Rev Respir Dis 1992:146:604-6.
11. Reimert CM, Ouma JH, Mwanje MT, et al. Indirect assessment of eosinophiluria in urinary schistosomiasis using eosinophil cationic protein (ECP) and eosinophil protein X (EPX). Acta Trop 1993;54:1-12.
12. Koller DY, Herouy Y, Gotz M, Hagel E, Urbanek R. Eichler I. Clinical value of monitoring eosinophil activity in asthma. Arch Dis Child 1995;73:413-17.
13. Kristjansson S, Strannegard IL, Strannegard Ö, Peterson C, Enander I, Wennergren G. Urinary eosinophil protein X in children with atopic asthma: a useful marker of anti-inflammatory treatment. J Allergy Clin Immunol 1996;97: 1179-87.
14. American Thoracic Society. Standardization of spirometry - 1987 update. Am Rev Respir Dis 1987;2:1285-98.
15. Zapletal A, Samanek M, Paul T. Lung function in children and adolescents. Methods, reference values. Prog Respir Res 1987;22:113-218.
16. Barnes PJ. Mechanisms of action of glucocorticoids in asthma. Am J Respir Crit Care Med 1996;154:S21-7.
17. Zimmerman B, Enander I, Zimmerman R, Ahlstedt S. Asthma in children less than 5 years of age: eosinophils and serum levels of the eosinophil proteins ECP and EPX in relation to atopy and symptoms. Clin Exp Allergy 1994;24:149-55.
18. Koller DY, Götz M, Eichler I, Urbanek R. Eosinophilic activation in cystic fibrosis. Thorax 1994;49:496-9.